O'Neil Global Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,810
| Closed | -$250K | – | 61 |
|
|
2024
Q1 | $250K | Buy |
1,810
+275
| +18% | +$38K | 0.31% | 26 |
|
|
2023
Q4 | $202K | Sell |
1,535
-663
| -30% | -$87.2K | 0.12% | 51 |
|
|
2023
Q3 | $247K | Buy |
+2,198
| New | +$247K | 0.22% | 46 |
|
|
2023
Q1 | – | Sell |
-3,280
| Closed | -$392K | – | 81 |
|
|
2022
Q4 | $392K | Sell |
3,280
-601
| -15% | -$71.8K | 1.81% | 22 |
|
|
2022
Q3 | $412K | Buy |
+3,881
| New | +$412K | 1.63% | 27 |
|